Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Asset Utilization Ratio (2021 - 2025)

Goldenwell Biotech filings provide 5 years of Asset Utilization Ratio readings, the most recent being 0.0 for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 131.89% to 0.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.0, a 131.89% decrease, with the full-year FY2024 number at 0.0, down 92.02% from a year prior.
  • Asset Utilization Ratio hit 0.0 in Q3 2025 for Goldenwell Biotech, up from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.22 in Q2 2023 to a low of 0.0 in Q2 2025.
  • Median Asset Utilization Ratio over the past 5 years was 0.01 (2023), compared with a mean of 0.06.
  • Biggest five-year swings in Asset Utilization Ratio: surged 3001.95% in 2022 and later crashed 131.89% in 2025.
  • Goldenwell Biotech's Asset Utilization Ratio stood at 0.04 in 2021, then skyrocketed by 383.91% to 0.19 in 2022, then tumbled by 93.93% to 0.01 in 2023, then crashed by 100.83% to 0.0 in 2024, then tumbled by 611.56% to 0.0 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.0 (Q3 2025), 0.0 (Q2 2025), and 0.0 (Q1 2025) per Business Quant data.